Diagnostic Accuracy of Combo Immunochromatographic Assay Kit in Comparison with ELISA for Detection of HBsAg, anti-HCV Antibody, and anti-HIV Antibody

Raza Ullah Asif; Eijaz Ghani; Muhammad Ali Rathore; Saadiya Mushtaq; Adnan Shehzad; Hina Saeed

doi:10.51253/pafmj.v76i4.12199

Authors

Raza Ullah Asif Department of Virology, Armed Forces Institute of Pathology, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
Eijaz Ghani Department of Virology, Armed Forces Institute of Pathology, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
Muhammad Ali Rathore Department of Virology, Armed Forces Institute of Pathology, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
Saadiya Mushtaq Department of Virology, Armed Forces Institute of Pathology, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
Adnan Shehzad Department of Virology, Armed Forces Institute of Pathology, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
Hina Saeed Department of Virology, Armed Forces Institute of Pathology, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan

DOI:

https://doi.org/10.51253/pafmj.v76i4.12199

Keywords:

Enzyme-Linked Immunosorbent Assay, Hepatitis B Surface Antigens, Hepatitis C Antibodies, HIV, Immunoassay, Point-of-Care Testing.

Abstract

Objective: To determine the diagnostic accuracy of combo Immunochromatographic (ICT) kit compared with Enzyme Linked Immunosorbent Assay (ELISA) to diagnose Hepatitis B, Hepatitis C, and HIV infection.

Place and Duration of Study: Department of Virology, Armed Forces Institute of Pathology Rawalpindi, Pakistan, from Jul to Dec 2023.

Study Design: Diagnostic accuracy study.

Methodology: A total of 1217 blood specimens were collected and tested for HBsAg, Anti-HCV Ab, and Anti-HIV Ab using both an ICT kit and ELISA. The results of positive and negative specimens on ICT were compared with ELISA, which was taken as gold standard. Sensitivity, specificity, positive predictive value, negative predictive value, diagnostic accuracy, and Kappa coefficient were calculated.

Results: Regarding HBsAg detection, the ICT kit showed 97.8% sensitivity, 99.8% specificity, a positive predictive value of 92.0%, and a negative predictive value of 99.9%. For anti-HCV antibodies, sensitivity was 98.8%, specificity 99.6%, a positive predictive value 93.5% and a negative predictive value 99.9%. For anti-HIV antibodies, sensitivity, specificity, positive predictive value, and negative predictive value were all 100.0%. Overall, the ICT kit demonstrated 99.0% diagnostic accuracy with a Kappa coefficient above 0.9, indicating excellent agreement with ELISA results.

Conclusion: The study highlighted the combo ICT kit as a cost-effective alternative to ELISA for detecting Hepatitis B, Hepatitis C, and HIV infections. With 99% diagnostic accuracy and a Kappa coefficient above 0.9, it demonstrated high sensitivity, specificity, PPV, and NPV.

Downloads

Download data is not yet available.

References

1. Luppa PB, Sokoll LJ, Chan DW. Immunosensors—principles and applications to clinical chemistry. Clinica Chimica Acta 2001; 314(1-2): 1-26. https://doi.org/10.1016/S0009-8981(01)00629-5

2. Zhang Y, Bu JW, Shu R, Liu SL. Advances in Rapid Point-of-Care Virus Testing. Analyst 2024; 149(9): 2507-2525.

https://doi.org/10.1039/d4an00238e

3. Mehmood S, Raza H, Abid F, Saeed N, Rehman HM, Javed S, et al. National prevalence rate of hepatitis B and C in Pakistan and its risk factors. J Public Health 2020; 28(1): 751-764.

https://doi.org/10.1007/s10389-019-01081-5

4. Haqqi A, Munir R, Khalid M, Khurram M, Zaid M, Ali M, et al. Prevalence of hepatitis C virus genotypes in Pakistan: current scenario and review of literature. Viral Immunol 2019; 32(9): 402-413. https://doi.org/10.1089/vim.2019.0058

5. Nazir Q, Awais M, Naeem J, Zahid A, Saleem R, Adeel M, et al. Prevalence and risk factors of hepatitis B virus and hepatitis C virus among pregnant women of Faisalabad, Punjab, Pakistan. J Med Health Sci Rev 2025; 2(2).

https://doi.org/10.62019/9xx4ga49

6. Tomasik A, Pokorska-Śpiewak M, Marczyńska M. Non-vertical exposures to HIV, HBV and HCV Infection in children and adolescents—risk of infection, standards of care and postexposure prophylaxis. Pediatr Rep 2021; 13(4): 566-575.

https://doi.org/10.3390/pediatric13040067

7. Coffin CS, Zhou K, Terrault NA. New and old biomarkers for diagnosis and management of chronic hepatitis B virus infection. Gastroenterology 2019; 156(2): 355-368.

https://doi.org/10.1053/j.gastro.2018.11.037

8. Jeng WJ, Yip TC, Lok AS. Hepatitis B: a review. JAMA 2026; 335(21): 1879-1892. https://doi.org/10.1001/jama.2026.6070

9. Zetola NM, Pilcher CD. Diagnosis and management of acute HIV infection. Infect Dis Clin N Am 2007; 21(1): 19-48.

https://doi.org/10.1016/j.idc.2007.01.008

10. Tiwari YK, Pundir S, Saraf G, Pawan K, Dashora D, Pokra M, et al. A comparison of rapid card test with enzyme-linked immunosorbent assay for the detection of hepatitis B surface antigen [HBsAg] in tertiary care hospital. Res Rev: J Microbiol Virol 2017; 7(3): 27-31.

11. Buderer NM. Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity. Acad Emerg Med 1996; 3(9): 895-900.

https://doi.org/10.1111/j.1553-2712.1996.tb03538.x

12. Sadeghi P, Sohrabi H, Hejazi M, Jahanban-Esfahlan A, Baradaran B, Tohidast M. Lateral flow assays (LFA) as an alternative medical diagnosis method for detection of virus species: The intertwine of nanotechnology with sensing strategies. TrAC Trends Anal Chem 2021; 145: 116460.

https://doi.org/10.1016/j.trac.2021.116460

13. Das D, Roy S, Mondal S. Evaluation of Performance Characteristics of Enzyme Chemiluminescence Immunoassay (ECLIA) and Rapid Diagnostic Test (RDT) for HBV, HIV and HCV Infections. J Clin Diagn Res 2018; 12(8).

https://doi.org/10.7860/JCDR/2018/35169.11877

14. Ayodeji AO, Ismai’la A, Umar SF. Comparative evaluation of chromatographic immunoassay and enzyme-linked immunosorbent assay in the diagnosis of hepatitis B viral infection in pregnancy. ARC J Hematol 2019; 4: 28-34.

15. Al-Matary AM, Al Gashaa FA. Comparison of different rapid screening tests and ELISA for HBV, HCV, and HIV among healthy blood donors and recipients at Jibla University Hospital Yemen. J Med Life 2022; 15(11): 1403.https://doi.org/10.25122/jml-2022-0051

16. Sanou AM, Toyé R, Kagoné T, Nikiéma A, Testa J, Sakandé J, et al. Analytical performance of eight rapid point-of-care tests routinely used for the detection of HBsAg in Burkina Faso: A cross-sectional study. J Clin Virol 2020; 129(1): 104546.

https://doi.org/10.1016/j.jcv.2020.104546

17. Muñoz-Chimeno M, Valencia J, Rodriguez-Recio A, Cuevas G, Garcia-Lugo A, Manzano S, et al. HCV, HIV AND HBV rapid test diagnosis in non-clinical outreach settings can be as accurate as conventional laboratory tests. Sci Rep 2023; 13(1): 7554.

https://doi.org/10.1038/s41598-023-33925-2

18. Ince B, Sezgintürk MK. Lateral flow assays for viruses’ diagnosis: Up-to-date technology and future prospects. TrAC Trends Anal Chem 2022; 157: 116725.

https://doi.org/10.1016/j.trac.2022.116725